Among the somatic mutations observed, activating mutations in the PIK3CA gene, encoding the catalytic subunit of PI3K, are the most frequently observed mutations accounting for 20–36% of cervical cancer tumors (17, 37, 44–46). This evidence concerns the gene PIK3CA and cervical carcinoma.